Your browser doesn't support javascript.
loading
RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness.
Novak, Tanya; Hall, Mark W; McDonald, Douglas R; Newhams, Margaret M; Mistry, Anushay J; Panoskaltsis-Mortari, Angela; Mourani, Peter M; Loftis, Laura L; Weiss, Scott L; Tarquinio, Keiko M; Markovitz, Barry; Hartman, Mary E; Schwarz, Adam; Junger, Wolfgang G; Randolph, Adrienne G.
Afiliação
  • Novak T; Boston Children's Hospital, Department of Anesthesiology, Critical Care and Pain Medicine, Boston, Mass; Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass; Department of Anesthesia, Harvard Medical School, Boston.
  • Hall MW; Nationwide Children's Hospital, Division of Critical Care Medicine, Department of Pediatrics, Columbus, Ohio.
  • McDonald DR; Boston Children's Hospital, Division of Immunology and Harvard Medical School Department of Pediatrics, Boston, Mass.
  • Newhams MM; Boston Children's Hospital, Department of Anesthesiology, Critical Care and Pain Medicine, Boston, Mass.
  • Mistry AJ; Boston Children's Hospital, Department of Anesthesiology, Critical Care and Pain Medicine, Boston, Mass.
  • Panoskaltsis-Mortari A; Cytokine Reference Laboratory, Department of Pediatrics, University of Minnesota, Minneapolis, Minn.
  • Mourani PM; Section of Critical Care Medicine, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colo.
  • Loftis LL; Section of Critical Care Medicine, Department of Pediatrics, Texas Children's Hospital, Houston, Tex.
  • Weiss SL; Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, Pa.
  • Tarquinio KM; Division of Pediatric Critical Care Medicine, Children's Healthcare of Atlanta at Egleston, Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga.
  • Markovitz B; Department of Anesthesiology Critical Care Medicine, Children's Hospital Los Angeles, Los Angeles, Calif.
  • Hartman ME; Department of Pediatrics, St Louis Children's Hospital, St Louis, Mo.
  • Schwarz A; Department of Pediatrics, Children's Hospital of Orange County, Orange, Calif.
  • Junger WG; Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
  • Randolph AG; Boston Children's Hospital, Department of Anesthesiology, Critical Care and Pain Medicine, Boston, Mass; Department of Anesthesia, Harvard Medical School, Boston. Electronic address: adrienne.randolph@childrens.harvard.edu.
J Allergy Clin Immunol ; 145(6): 1673-1680.e11, 2020 06.
Article em En | MEDLINE | ID: mdl-32035159
ABSTRACT

BACKGROUND:

Decreased TNF-α production in whole blood after ex vivo LPS stimulation indicates suppression of the Toll-like receptor (TLR)4 pathway. This is associated with increased mortality in pediatric influenza critical illness. Whether antiviral immune signaling pathways are also suppressed in these patients is unclear.

OBJECTIVES:

We sought to evaluate suppression of the TLR4 and the antiviral retinoic acid-inducible gene-I (RIG-I) pathways with clinical outcomes in children with severe influenza infection.

METHODS:

In this 24-center, prospective, observational cohort study of children with confirmed influenza infection, blood was collected within 72 hours of intensive care unit admission. Ex vivo whole blood stimulations were performed with matched controls using the viral ligand polyinosinic-polycytidylic acid-low-molecular-weight/LyoVec and LPS to evaluate IFN-α and TNF-α production capacities (RIG-I and TLR4 pathways, respectively).

RESULTS:

Suppression of either IFN-α or TNF-α production capacity was associated with longer duration of mechanical ventilation and hospitalization, and increased organ dysfunction. Children with suppression of both RIG-I and TLR4 pathways (n = 33 of 103 [32%]) were more likely to have prolonged (≥7 days) multiple-organ dysfunction syndrome (30.3% vs 8.6%; P = .004) or prolonged hypoxemic respiratory failure (39.4% vs 11.4%; P = .001) compared with those with single- or no pathway suppression.

CONCLUSIONS:

Suppression of both RIG-I and TLR4 signaling pathways, essential for respective antiviral and antibacterial responses, is common in previously immunocompetent children with influenza-related critical illness and is associated with bacterial coinfection and adverse outcomes. Prospective testing of both pathways may aid in risk-stratification and in immune monitoring.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Receptor 4 Toll-Like / Influenza Humana / Proteína DEAD-box 58 Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Receptor 4 Toll-Like / Influenza Humana / Proteína DEAD-box 58 Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article